Back

Axsome Therapeutics Quote, Financials, Valuation and Earnings

Buy

AXSM
Axsome Therapeutics

Last Price:

76.90

Seasonality Move:

-2.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Axsome Therapeutics Price Quote

$76.90

+1.71 (+2.27%)

(Updated: May 28, 2024 at 4:55 PM ET)

Axsome Therapeutics Key Stats

Buy

Axsome Therapeutics (AXSM) is a Buy

Day range:

$74.19 - $75.41

52-week range:

$55.02 - $98.40

Dividend yield:

P/E ratio:

0.00

P/S ratio:

13.89

P/B ratio:

24.79%

Volume:

377.2K

Avg. volume:

558.4K

1-year change:

9.4%

Market cap:

$3.6B

Revenue:

$270.6M

EPS:

$-6.38

How Much Does Axsome Therapeutics Make?

How Much Are Axsome Therapeutics's Sales Annually?
AXSM Revenues are $270.6M
How Much Profit Does Axsome Therapeutics's Make A Year?
AXSM net income is -$239.2M

Is Axsome Therapeutics Growing As A Company?

What Is Axsome Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.21%
What Is Axsome Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Axsome Therapeutics Stock Price Performance

Did Axsome Therapeutics Stock Go Up Last Month?
Axsome Therapeutics share price went up by 5.65% last month
Did AXSM's Share Price Rise Over The Last Year?
AXSM share price rose by 9.4% over the past 1 year

What Is Axsome Therapeutics 52-Week High & Low?

What Is Axsome Therapeutics’s 52-Week High Share Price?
Axsome Therapeutics has traded as high as $98.40 over the past 52 weeks
What Is Axsome Therapeutics’s 52-Week Low Share Price?
Axsome Therapeutics has traded as low as $55.02 over the past 52 weeks

Axsome Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Axsome Therapeutics?

How Much Debt Does Axsome Therapeutics Have?
Total long term debt quarterly is $178.7M
How Much Cash Does Axsome Therapeutics Have?
Cash and short term investments quarterly total is $331.4M
What Is Axsome Therapeutics’s Book Value Per Share?
Book value per share is 3.03

Is Axsome Therapeutics Cash Flow Positive?

What Is AXSM Cash Flow From Operations?
Cash flow from operations (TTM) is -$192.7M
What Is Axsome Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $278.3M
What Is Axsome Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$609K

Axsome Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
AXSM return on invested capital is -79.94%
What Is Axsome Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -54.17%
What Is AXSM Return On Equity?
ROE is a measure of profitability and is -148.91%

Axsome Therapeutics Earnings Date & Stock Price

What Is Axsome Therapeutics's Stock Price Today?
A single share of AXSM can be purchased today for 75.19
What Is Axsome Therapeutics’s Stock Symbol?
Axsome Therapeutics trades on the nasdaq under the ticker symbol: AXSM
When Is Axsome Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Axsome Therapeutics is scheduled on August 7, 2024
When Is AXSM's next ex-dividend date?
Axsome Therapeutics's next ex-dividend date is May 28, 2024
How To Buy Axsome Therapeutics Stock?
You can buy Axsome Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Axsome Therapeutics Competitors

Who Are Axsome Therapeutics's Competitors?
Below is a list of companies who compete with Axsome Therapeutics or are related in some way:
- ADMA Biologics Inc (ADMA)
- Catalyst Pharmaceuticals Inc (CPRX)
- Krystal Biotech Inc (KRYS)
- Vertex Pharmaceuticals Inc (VRTX)
- Vistagen Therapeutics Inc (VTGN)

Axsome Therapeutics Dividend Yield